SCHEMBL5140132

SCHEMBL5140132

C=CCc1[c]oc2ccccc2c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 4/20 0.40
MAOA P21397 3/20 0.40
MAPT P10636 3/20 0.40
GLA P06280 2/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
PGAM1 P18669 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
MAOB P27338 4/20 0.36
PTPN1 P18031 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5134333 0.88 CA12 (0.34) MAPTCYP3A4CA12CA1CA9
SCHEMBL2215928 0.72 CA12 (0.43) KDM4EALDH1A1MAOAMAPTGLA
SCHEMBL10514896 0.70 L3MBTL1 (0.33) KDM4EALDH1A1MAOAMAPTGLA
SCHEMBL3538088 0.70 ALDH1A1 (0.33) KDM4EALDH1A1MAOAMAPTGLA
SCHEMBL7674731 0.69 MAOA (0.47) KDM4EALDH1A1MAOAMAPTGLA
SCHEMBL5676277 0.69 MAOB (0.65) KDM4EALDH1A1MAOAMAPTGLA
Ammonia Solution, Strong SCHEMBL28664277 0.68 MAOB (0.63) KDM4EALDH1A1MAOAMAPTGLA
SCHEMBL15822903 0.67 MAOA (0.47) KDM4EALDH1A1MAOAMAPTGLA
SCHEMBL2197293 0.67 CALM1 (0.41) MAPTHPGDCA12CA9PTPN1
SCHEMBL5677951 0.67 MAOA (0.47) KDM4EALDH1A1MAOAMAPTGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US claimed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US claimed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO claimed
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US disclosed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US disclosed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof CTRL, PRCP, CLPP KDM4E 2744/4885ALDH1A1 740/4885MAOA 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.